Axsome Therapeutics, Inc. (AXSM)
NASDAQ: AXSM · Real-Time Price · USD
90.35
+0.24 (0.27%)
Oct 29, 2024, 4:00 PM EDT - Market closed
Axsome Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -308.55 | -239.24 | -187.13 | -130.4 | -102.9 | -68.35 | Upgrade
|
| Depreciation & Amortization | 0.93 | 0.46 | 0.26 | 0.08 | 0.08 | 0.04 | Upgrade
|
| Other Amortization | 8.72 | 8.95 | 5.62 | 1.08 | 0.79 | 0.65 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | - | 7.16 | - | Upgrade
|
| Stock-Based Compensation | 75.33 | 62.62 | 37.73 | 20.8 | 14.76 | 6.12 | Upgrade
|
| Other Operating Activities | 45.55 | 50.52 | 3.34 | -0.1 | 1.26 | - | Upgrade
|
| Change in Accounts Receivable | -52.93 | -57.12 | -37.7 | - | - | - | Upgrade
|
| Change in Inventory | -2.64 | -8.16 | -1.33 | - | - | - | Upgrade
|
| Change in Accounts Payable | 18.38 | 2.07 | 25.46 | -0.36 | 2.56 | 7.26 | Upgrade
|
| Change in Other Net Operating Assets | 47.73 | 34.81 | 37.24 | 0.68 | -2.15 | 7.91 | Upgrade
|
| Operating Cash Flow | -167.49 | -145.08 | -116.51 | -108.23 | -78.46 | -46.38 | Upgrade
|
| Capital Expenditures | -0.53 | -0.58 | -0.7 | -0.31 | -0.05 | -0.02 | Upgrade
|
| Cash Acquisitions | - | - | -53 | - | - | - | Upgrade
|
| Investing Cash Flow | -0.53 | -0.58 | -53.7 | -0.31 | -0.05 | -0.02 | Upgrade
|
| Long-Term Debt Issued | - | 85 | 45 | - | 50 | 20 | Upgrade
|
| Long-Term Debt Repaid | - | - | - | - | -21.66 | -7.24 | Upgrade
|
| Total Debt Repaid | -0.35 | - | - | - | -21.66 | -7.24 | Upgrade
|
| Net Debt Issued (Repaid) | -0.35 | 85 | 45 | - | 28.34 | 12.76 | Upgrade
|
| Issuance of Common Stock | 59.72 | 271.17 | 250.01 | 11.84 | 15.18 | 239.63 | Upgrade
|
| Repurchase of Common Stock | -3.58 | -1.84 | -0.53 | -0.18 | - | - | Upgrade
|
| Other Financing Activities | -9.23 | -23.32 | -9.9 | -0.53 | -1.1 | - | Upgrade
|
| Financing Cash Flow | 46.56 | 331.01 | 284.58 | 11.13 | 42.41 | 252.39 | Upgrade
|
| Net Cash Flow | -121.46 | 185.35 | 114.37 | -97.4 | -36.09 | 206 | Upgrade
|
| Free Cash Flow | -168.02 | -145.66 | -117.21 | -108.53 | -78.5 | -46.39 | Upgrade
|
| Free Cash Flow Margin | -57.64% | -53.83% | -234.25% | - | - | - | Upgrade
|
| Free Cash Flow Per Share | -3.55 | -3.21 | -2.88 | -2.89 | -2.11 | -1.36 | Upgrade
|
| Cash Interest Paid | 19.51 | 16.73 | 7.69 | 4.63 | 2.1 | 1.29 | Upgrade
|
| Levered Free Cash Flow | -77.13 | -78.72 | -42.36 | -59.52 | -47.37 | -20.73 | Upgrade
|
| Unlevered Free Cash Flow | -77.07 | -77.26 | -39.26 | -57.04 | -46.55 | -20.61 | Upgrade
|
| Change in Net Working Capital | -4.53 | 31.82 | -28.94 | -0.33 | -0.59 | -15.2 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.